Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Takeda Pharmaceutical Company Limited American Depositary Shares (each (NY:TAK)

18.26 +0.15 (+0.83%)
Official Closing Price Updated: 7:00 PM EDT, Sep 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Vertex Pharma Stumbles In Rare-Disease Effort, Buoying Rival Arrowhead Pharma ↗
Vertex Pharmaceuticals scrapped development of a rare-disease treatment Thursday that appeared unlikely to benefit patients, and VRTX stock plunged. 
Via Investor's Business Daily
News headline image
Blueprint for Access to Innovative Healthcare Episode 1: Awareness and Prevention
SOURCE: Takeda 
Via 3BL Media
News headline image
Wednesday News And Catch-Up ↗
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA. 
Via Talk Markets
Topics Stocks
News headline image
Global Diversity, Equity, and Inclusion Week at Takeda
SOURCE: Takeda 
Via 3BL Media
News headline image
Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
How Significant Are Moderna's Asian Regulatory Wins? ↗
The biotech is poised to profit in both Japan and South Korea. 
Via The Motley Fool
News headline image
A Better Switch ↗
Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase. 
Via Talk Markets
News headline image
Fan Hit ↗
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares. 
Via Talk Markets
News headline image
Wonder Products ↗
Meme is alive and well. 
Via Talk Markets
News headline image
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates ↗
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive... 
Via Benzinga
News headline image
New New Deal Worries ↗
Nio is up 1.4% today on another round of Meme buying. 
Via Talk Markets
News headline image
Good Times For Gold ↗
Gold is rising some more, in part as an alternative to crypto. 
Via Talk Markets
News headline image
Sterling At Five-Year High ↗
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro. 
Via Talk Markets
News headline image
Takeda's Dengue Vaccine Effective In Reducing Hospitalization Regardless Of Prior Infection ↗
Takeda Pharmaceutical Co Ltd (NYSE: TAK) unveiled long-term data for its dengue vaccine candidate (TAK-003), showing the shot’s efficacy waned over time but... 
Via Benzinga
News headline image
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Worldwide Upbeat ↗
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA. 
Via Talk Markets
Topics Economy
News headline image
Takeda's Maribavir US Application For Post-Transplant CMV Infection Under Review ↗
The FDA has accepted for review Takeda Pharmaceutical Co Ltd's (NYSE TAK) marketing application for maribavir for cytomegalovirus (CMV) Infection. The... 
Via Benzinga
News headline image
Moderna's COVID-19 Vaccine Scores Emergency Use Nod In Japan ↗
Moderna Inc (NASDAQ: MRNA) has received emergency use approval for its mRNA COVID-19 vaccine in Japan. Takeda Pharmaceutical Co Ltd (NYSE: TAK),... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Is BioCryst a Good Stock to Buy Now? ↗
This commercial-stage drugmaker trades for less than many of its clinical-stage peers. 
Via The Motley Fool
News headline image
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Better Mood Day ↗
The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion. 
Via Talk Markets
News headline image
Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG® (ponatinib), Reinforcing Ability to Address Gaps in Care for Chronic-Phase CML
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Takeda Presents Updated Results for Mobocertinib, Further Substantiating the Clinical Benefit in Patients with EGFR Exon20 Insertion+ mNSCLC
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Takeda FY20 Profit Surges, Revenue Drops; Guides For Weak FY21 Profit ↗
Takeda Pharmaceutical Co Ltd (NYSE: TAK) reported an FY20 net profit of ¥376 billion, a 750% Y/Y increase, reflecting gains on non-core asset sales and... 
Via Benzinga
News headline image
Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day ↗
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first... 
Via Benzinga
News headline image
Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021
From Takeda Pharmaceutical Company Limited
Via Business Wire
News headline image
Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares ↗
Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the... 
Via Benzinga
News headline image
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings ↗
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ: 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.